User menu

Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.

Bibliographic reference Rahier, Jean-François ; Druez, Anne ; Faugeras, Laurence ; Martinet, Jean-Paul ; GÉHÉNOT, Myriam ; et. al. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.. In: Clinical Epigenetics, Vol. 9, no.1, p. 53 (2017)
Permanent URL
  1. Ferlay Jacques, Soerjomataram Isabelle, Dikshit Rajesh, Eser Sultan, Mathers Colin, Rebelo Marise, Parkin Donald Maxwell, Forman David, Bray Freddie, Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 : Globocan 2012, 10.1002/ijc.29210
  2. DeSantis CE, Chieh Lin C, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–71.
  3. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9.
  4. Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology. 2014;146(3):709–17.
  5. Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64(10):1637-49.
  6. Winawer SJ, Fischer SE, Levin B. Evidence-based, reality-driven colorectal cancer screening guidelines: the critical relationship of adherence to effectiveness. JAMA. 2016;315(19):2065–6.
  7. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490–502.
  8. Kedrin D, Gala MK. Genetics of the serrated pathway to colorectal cancer. Clin Transl Gastroenterol. 2015;6(4):84.
  9. Füllgrabe J, Kavanagh E, Joseph B. Histone onco-modifications. Oncogene. 2011;30(31):3391–403.
  11. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426–37.
  12. Elshimali Yahya, Khaddour Husseina, Sarkissyan Marianna, Wu Yanyuan, Vadgama Jaydutt, The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients, 10.3390/ijms140918925
  13. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532–5.
  14. Kessenbrock K, Krumbholz M, Schönermarck U, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15(6):623–5.
  15. Summers T, Langan RC, Nissan A, et al. Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection. J Cancer. 2013;4(3):210–6.
  16. Jin H, Ma Y, Shen Q, et al. Circulating methylated DNA as biomarkers for cancer detection. In: Dricu A, editor. Methylation - from DNA, RNA and Histones to Diseases and Treatment. Rijeka: InTech; 2013. p. 137–52.
  17. deVos T, Tetzner R, Model F, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem. 2009;55(7):1337–46.
  18. Holdenrieder S, Dharuman Y, Standop J, et al. Novel serum nucleosomics biomarkers for the detection of colorectal cancer. Anticancer Res. 2014;34(5):2357–62.
  19. Bauden M, Pamart D, Ansari D, et al. Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer. Clin Epigenetics. 2015;7:106.
  20. Gezer U, Yörüker EE, Keskin M, Kulle CB, Dharuman Y, Holdenrieder S. Histone methylation marks on circulating nucleosomes as novel blood-based biomarker in colorectal cancer. Int J Mol Sci. 2015;16(12):29654–62.
  21. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL . R Found Stat Comput Vienna, Austria. 2015:2015.
  22. Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24(33):5313–27.